JOURNAL OF TELEMEDICINE AND TELECARE, published by SAGE PUBLICATIONS LTD, stands at the forefront of the rapidly evolving fields of health informatics and telemedicine. With its ISSN 1357-633X and E-ISSN 1758-1109, this prestigious journal has been a vital platform for innovation and research since its inception in 1995, covering a wide array of topics from remote patient monitoring to the integration of artificial intelligence in healthcare delivery. Recognized for its rigorous academic standards, the journal boasts an impressive impact factor, positioning it in the Q1 quartile for Health Informatics and securing a remarkable rank of #9 out of 138 in Scopus, placing it in the 93rd percentile among its peers. By disseminating high-quality research, the JOURNAL OF TELEMEDICINE AND TELECARE contributes significantly to the advancement of knowledge, shaping best practices in telehealth and enhancing patient care worldwide. As a non-open access journal, it appeals to a broad audience of researchers, healthcare professionals, and students, facilitating critical discourse on the future of healthcare technology. Stay at the forefront of this essential domain by engaging with the latest findings and projects featured in this influential publication.

Internet Interventions: The Application of Information Technology in Mental and Behavioural Health is a premier Open Access journal published by Elsevier, specializing in the intersection of technology and mental health. With an ISSN of N/A and E-ISSN 2214-7829, this journal provides a platform for innovative research that addresses the burgeoning field of digital mental health solutions. Since its inception in 2014, it has rapidly established significance within the academic community, evidenced by its impressive Q1 ranking in Health Informatics and its 72nd percentile ranking among 138 journals in the same category, as per Scopus metrics. By offering Open Access articles, the journal ensures that research findings are accessible to a wider audience, thereby promoting collaboration and knowledge sharing. Covering a diverse range of topics from online therapy to behavioral monitoring applications, the journal aims to advance academic discourse and practical applications in mental and behavioural health. Engage with cutting-edge research that shapes the future of healthcare technology and impacts real-world practices.

Contemporary Clinical Trials Communications, published by ELSEVIER INC, serves as a pivotal resource in the evolving fields of medicine and pharmacology, especially with its commitment to open access since 2015. With the E-ISSN 2451-8654, this journal is dedicated to disseminating high-quality research that examines contemporary clinical trial methodologies and their applications in improving healthcare outcomes. Situated in the United States, its impressive ranking, with a Q2 status in both Medicine (miscellaneous) and Pharmacology for 2023, highlights its significance and impact within the scientific community. Ranking #199 out of 636 in General Medicine and #217 out of 313 in Pharmacology on the Scopus scale, the journal aims to foster innovative discussions and developments among researchers, professionals, and students, making it an essential tool for those seeking to stay at the forefront of clinical research and trials.

The New England Journal of Medicine (NEJM), published by the Massachusetts Medical Society, stands as a beacon of excellence in the field of medicine. With an impressive impact factor and a prestigious rank of #2 out of 636 in General Medicine, NEJM is recognized in the Q1 category for its significant contributions to medical research and clinical practice since its inception in 1945. The journal is renowned for publishing groundbreaking studies, reviews, and commentaries that influence clinical guidelines and healthcare policies worldwide. While the journal is not open access, it provides pivotal resources that are essential for researchers, healthcare professionals, and students looking to stay abreast of the latest developments in medicine. With a commitment to advancing medical knowledge, NEJM plays a crucial role in bridging the gap between laboratory research and clinical application.

Journal of Comparative Effectiveness Research is a leading academic journal dedicated to the evaluation of healthcare interventions and practices, published by Becaris Publishing. Since transitioning to a fully Open Access model in 2023, the journal has expanded its accessibility to a global audience of researchers, healthcare professionals, and policy makers. With a focus on comparative effectiveness in health policy, it has achieved a notable ranking of #132 out of 310 in the Scopus category for Medicine and Health Policy, placing it in the 57th percentile for scholarly impact. Operating from the United Kingdom, the journal encompasses research from 2012 to 2024 and firmly establishes itself in the academic landscape as a Q2 journal in the Health Policy category as of 2023. By disseminating high-quality, evidence-based research, the Journal of Comparative Effectiveness Research plays a vital role in informing clinical practice and health policy decision-making, making it an essential resource for those dedicated to improving health outcomes.

Health Policy and Technology is a prestigious academic journal published by ELSEVIER SCI LTD that has established itself as a leader in the fields of Biomedical Engineering and Health Policy. With an impressive Q1 ranking in both disciplines as of 2023, the journal offers a platform for original research, reviews, and innovative technological solutions that aim to bridge the gap between health policy and technology. Since its inception in 2012, it has served as a vital resource for researchers, professionals, and students who are seeking to explore the impact of technology on healthcare systems and policies globally. Although it is not an open-access journal, the high-quality, peer-reviewed articles published within its pages contribute significantly to the discourse on the advancement of healthcare practices. The journal's commitment to disseminating groundbreaking studies ensures it remains a crucial reference point in these rapidly evolving fields.

Clinical Therapeutics, published by Elsevier, is a highly esteemed peer-reviewed journal that has been pivotal in advancing the field of pharmacology since its inception in 1977. With an impressive impact factor and recognition as Q2 in Pharmacology and Q1 in Medical Pharmacology for 2023, it stands at the forefront of research and discussions on innovative therapeutic strategies and pharmacological advancements. This journal not only caters to a broad audience of researchers and clinicians but also plays a vital role in disseminating critical information that supports the enhancement of patient care and safety. As a repository of high-quality, evidence-based articles, Clinical Therapeutics is a crucial resource for those involved in drug development, medical research, and clinical practice, making it an essential read for anyone dedicated to improving health outcomes through pharmaceutical sciences.

Value in Health Regional Issues, published by Elsevier, is an essential academic journal that addresses critical developments in the field of health economics, policy, and pharmaceuticals. With an impressive impact factor, this journal has established itself as a leading platform for disseminating innovative research, evidenced by its Q1 quartile ranking in Economics, Econometrics and Finance and Pharmacology, Toxicology and Pharmaceutics. Founded in 2012, the journal is dedicated to exploring value-based healthcare, focusing on regional perspectives that highlight economic implications and health outcomes. Covering a convergence of multidisciplinary themes, the journal fosters academic collaboration and provides researchers, professionals, and students with access to high-quality, peer-reviewed articles. As it continues to expand its scope through 2025, Value in Health Regional Issues remains a pivotal resource for those seeking to understand and influence health policy and economic frameworks on a regional, national, and global scale.

PHARMACOECONOMICS, published by ADIS INT LTD, is a prestigious international journal dedicated to disseminating research in the fields of health policy, pharmacology, and public health. With an impressive impact factor and a solid Q1 ranking across its relevant categories, this journal plays a crucial role in shaping policy decisions, optimizing health resources, and enhancing pharmacoeconomic evaluations globally. The journal not only targets researchers and professionals but also serves as an invaluable resource for students striving to understand the economic implications of pharmaceutical care. Operating since 1992 and continuously evolving through 2024, PHARMACOECONOMICS invites contributions that address the complexities of drug expenditure, health outcomes, and public health implications, thereby fostering informed decision-making in healthcare systems. Readers can explore cutting-edge studies and analyses aimed at balancing cost-effectiveness with clinical effectiveness, making this journal a cornerstone for stakeholders invested in the future of health economics.

The Cochrane Database of Systematic Reviews is a premier journal published by WILEY, focusing on the critical appraisal and synthesis of high-quality research in health care. With its dedication to evidence-based practice, this journal serves as a cornerstone for researchers, healthcare professionals, and students alike, offering pivotal insights through rigorous systematic reviews. Although it is not an open-access publication, its influence in guiding clinical decision-making and policy formulation is profound, underscored by its contributions to the advancement of healthcare knowledge. Based in the United States at 111 River St, Hoboken, NJ, the Cochrane Database has established itself as essential reading for those seeking to stay at the forefront of systematic reviews and meta-analyses in the medical field, ensuring that users are well-equipped with the evidence necessary for informed practice.